A follow-up study of colour vision in two patients with gyrate atrophy was performed. Gyrate atrophy was diagnosed in the first patient at the age of 17 years. Her colour vision was first tested at the age of 25 years; at the follow-up examination 7 years later, she correctly interpreted the Standard Pseudoisochromatic Plates part 2, however, with one mistake due to lens opacity. In the Farnsworth-Munsell 100 hue test and in the Color Vision Meter 712 (CVM) anomaloscope, the results were within normal ranges. In the second patient, gyrate atrophy was diagnosed at the age of 4 years. At the ages of 4 and 5 years, he correctly interpreted the Ishihara, AO H-R-R, and Lanthony Tritan Album plates as well as the City University test. At the ages of 6, 7, and 8 years, he correctly interpreted the plate tests, the Farnsworth Panel D 15, and Lanthony's Desaturated Panel. The CVM anomaloscope results were normal.
Introduction
Gyrate atrophy is a hereditary chorioretinal dystrophy characterized by round whitish atrophic spots in the periphery of the eye fundus. This disease has been found to begin in childhood or at school age. However, the disease has even been reported in a 1-year-old [1] . Onset at adult age has also been observed [2] . High myopia, poor visual acuity, decreased dark adaptation, and defects in visual fields are found in an eye examination. These findings progress gradually with age, and at late middle age these patients can be severely visually handicapped because of visual loss and concentric constriction of the visual fields. Gyrate atrophy is inherited as an autosomal recessive trait, and it belongs to Finnish inherited diseases, the frequency being highest in Finland, 1:50000 [3, 4] . A metabolic error -a high ornithine level-has been found in the blood of these patients due to a defect in the ornithine-aminotransferase enzyme [1] . The therapy consists of a low arginine diet with pyridoxine supplementation. The gene of this disease has been mapped to chromosome 10, 10 q 26 [5] .
Normal colour vision [2, 6, 7] as well as acquired red defects [8] [9] [10] , blue defects [2, 6] , achromatopsia [11] and irregular colour vision defects without diagnosis [6, 12] have been observed in patients with gyrate atrophy.
The purpose of the present study is to report followup observations of colour vision in two patients with gyrate atrophy.
Results

Case reports
Case 1
Gyrate atrophy was diagnosed in this 31-year-old woman at the age of 17 years. Colour vision was regularly studied since she was 25 years of age. Her blood ornithine level was eight times higher than normal, and subsequent genetic studies also confirmed the disease. She had been under treatment only for 4 years, from the age of 25 years until her first pregnancy at the age of 29. As she wants to have more children, she has further refused therapy. During the follow-up, her visual acuity decreased from 0.5 to 0.3 (6/12-6/18) in the right and from 0.4 to 0.1 (6/15-6/60) in the left eye. In the latest examination, the visual fields (Peristat, Rodenstock, Munich, Germany) were tubular, 15°in the right and 10°in the left eye. In the dark adaptation examination, the cone threshold was normal and the rod threshold was elevated 0.8 log units in both eyes (Goldmann-Weekers, Haag-Streit, Bern, Switzerland). Very slight onset of a posterior pole cataract was detected in both eyes from the age of 28 years. In the left eye, the cataract had progressed to a dense opacity in the latest examination. In both eyes, the eye fundus showed typical multiple round white atrophic spots in the periphery (Fig. 1) . She interpreted the Standard Pseudoisochromatic Plates part 2 [13] correctly; only on the latest visit did the left eye with the cataract miss one of the blue numbers. In the Farnsworth -Munsell 100 hue test, FM 100 [14] , she had normal age-matching error scores [15, 16] without axis formation [17] during the follow-up (Table 1) ; on the latest visit, because of the cataract, the error scores of the left eye had increased being at the upper limit of the normal score. The Color Vision Meter 712 automatic anomaloscope, CVM (Interzeag, Schlieren, Switzerland) results were normal and nearly the same on every visit (Table 1) .
Case 2
Gyrate atgrophy was diagnosed in this 8-year-old boy at the age of 4 years. Initially, his visual acuity was 0.2 (6/30) in both eyes with a refraction of − 3.0 D cyl − 3.5 D× 5°in the right and − 3.5 D cyl − 3.0 D×0°i n the left eye. The visual acuity could be better examined as the patient grew older; at the age of 8 years, it was 0.5 (6/12) in both eyes. The myopic refraction had become higher, being −5.0 D cyl − 3.5 D× 15°in the right and − 6.0 D cyl − 3.0 D × 0°in the left eye. In the eye fundus, the typical multiple round white atrophic spots were seen. Examination of the visual fields was unreliable, but could be interpreted as tubular, 15°in the right and 20°in the left eye (Friedman Central Field Analyzer, Clement Clarke, London, UK). It has not yet been possible to perform the dark adaptation examination. His blood ornithine level was 20 times higher than normal, and subsequent genetic studies also confirmed the disease. He has been under therapy since the diagnosis was made; however, his blood ornithine level is still high. At the age of 4 or 5, very few colour vision tests can be reliably used. We examined the patient with Ishihara's Design Charts for Colour-Blindness of Unlettered Persons [18] , Lanthony Tritan Album [19] , AO H-R-R plates [20] , and the City University test [21] . The patient could interpret these tests very reliably, showing normal results in both eyes. At the ages of 6-8 years, he passed the plate tests as well as the Farnsworth Panel D 15 [22] . He could also do the difficult Lanthony Desaturated Panel [23] without any major errors. Moreover, the CVM anomaloscope could be used at the ages of 7 and 8, and the results were normal ( Table  2) . 
Discussion
The colour vision of our gyrate atrophy patients aged 31 and 8 years was observed for 7 and 5 years, respectively, and found to be normal. However, there were changes within normal ranges in the adult patient, Case 1. The first FM 100 test of the right eye at the age of 26 years probably produced a poor score because of the newness of the test for the patient. The score of the left eye was already better then and within the normal range; it has been observed in earlier studies too that the performance of the FM 100 hue test can improve with experience [16] . The following years showed quite similar scores within the normal limits in both eyes in the FM 100 test except on the last visit, when the progressing cataract most probably decreased the score of the left eye. Her CVM anomaloscope results were normal in both eyes. The results were almost the same in the red-green equation in the right eye during the follow-up, but had a tendency to shift to green in the left eye, probably also because of the developing cataract. The blue equation was about the same during the follow-up in both eyes, although one would have expected to see a shift to blue in the cataractous left eye.
In the younger patient, Case 2, the CVM anomaloscope testing was possible at the ages of 7 and 8 years, and the results were within the normal ranges. The red-green equation was quite similar in both eyes, but the blue equation showed a slight shift within the normal range to blue in the right eye. The matching ranges of the blue equation in both eyes were at the upper limit of normal, as frequently observed in young children, but in some adults too.
It is surprising that colour vision can show normal function even if fundus changes are extensive and the visual fields are almost tubular. Probably the cone area responsible for colour vision is quite narrow at the fovea and so the influence of the peripheral atrophic changes reaches this area much later. In a study of a family with dominant retinitis pigmentosa in three generations, the oldest member of the family had tubular fields of about 10°in both eyes but still had normal colour vision [24] .
Reports on the therapy of gyrate atrophy are controversial: the therapy with reduced blood ornithine level has not always prevented the deterioration of eye functions [25, 26] . On the other hand, the results of KaiserKupfer et al. [1] have shown that long-term reduction of blood ornithine level slows the progression of this disease. Our younger patient, Case 2, also had therapy, but his blood ornithine level had remained high. The adult patient, Case 1, had had the therapy only for 4 years and had been without it for 3 years at the time of this study. It is thus difficult to claim that the preserved colour vision in our patients is due to the therapy. 
